A phase I/II open label study to evaluate the safety, cellular kinetics, and efficacy of AZD0754, a chimeric antigen receptor (car) t-cell therapy directed against STEAP2, in adult participants with metastatic prostate cancer: APOLLO

MyChart

Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
Request an Appointment

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information

New Patients Current Patients Referring Physicians
Donate Today